The CD44+/CD24− phenotype is commonly linked to tumor-initiating potential in basal-like breast cancer.139 However, this correlation is inconsistent across subtypes, and CD24− cells do not always exhibit enhanced stemness. This evidence concerns the gene CD44 and breast carcinoma.